GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $63,217,000 | +24.4% | 604,604 | +66.0% | 3.86% | +17.7% |
| Q2 2018 | $50,834,000 | +65.4% | 364,300 | +33.6% | 3.28% | +16.8% |
| Q1 2018 | $30,725,000 | -65.5% | 272,700 | -59.6% | 2.81% | -65.1% |
| Q4 2017 | $89,172,000 | +45.9% | 675,492 | +12.2% | 8.05% | +19.2% |
| Q3 2017 | $61,102,000 | – | 602,047 | – | 6.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |